Teacher Retirement System of Texas Portfolio holdings
AUM
$23.8B
1-Year Return
25.15%
This Quarter Return
+8.91%
1 Year Return
+25.15%
3 Year Return
+104.39%
5 Year Return
+185.58%
10 Year Return
+422.47%
AUM
$14.9B
AUM Growth
+$31.2M
(+0.21%)
Cap. Flow
-$1.01B
Cap. Flow
% of AUM
-6.8%
Top 10 Holdings %
Top 10 Hldgs %
23.45%
Holding
2,146
New
60
Increased
546
Reduced
1,311
Closed
214
Top Buys
| 1 |
Mercado Libre
MELI
|
$29.4M |
| 2 |
Revvity
RVTY
|
$21.7M |
| 3 |
Builders FirstSource
BLDR
|
$21.5M |
| 4 |
StoneCo
STNE
|
$19.8M |
| 5 |
PTC
PTC
|
$19M |
Top Sells
| 1 |
Apple
AAPL
|
$97.8M |
| 2 |
Microsoft
MSFT
|
$65M |
| 3 |
Amazon
AMZN
|
$41M |
| 4 |
Life Time Group Holdings
LTH
|
$38.4M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
$31.4M |
Sector Composition
| 1 | Technology | 23.49% |
| 2 | Healthcare | 11.99% |
| 3 | Consumer Discretionary | 11.59% |
| 4 | Financials | 10.87% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Arcutis Biotherapeutics
ARQT
$2.06B
| $111K | ﹤0.01% |
11,600
-1,539
| -12% | -$14.7K |
|
|
EQRX
1852
DELISTED
EQRx, Inc. Common Stock
EQRX
| $111K | ﹤0.01% |
59,426
+14,286
| +32% | +$26.7K |
|
1853
AvidXchange
AVDX
$2.06B
| $110K | ﹤0.01% |
+10,557
| New | +$110K |
|
1854
Nurix Therapeutics
NRIX
$758M
| $109K | ﹤0.01% |
10,926
+33
| +0.3% | +$329 |
|
1855
Lyell Immunopharma
LYEL
$233M
| $108K | ﹤0.01% |
+1,693
| New | +$108K |
|
1856
Rocket Lab Corporation Common Stock
RKLB
$22.1B
| $108K | ﹤0.01% |
18,057
+2,266
| +14% | +$13.6K |
|
1857
Aldeyra Therapeutics
ALDX
$334M
| $107K | ﹤0.01% |
+12,713
| New | +$107K |
|
1858
Scilex Holding
SCLX
$159M
| $107K | ﹤0.01% |
549
| – | – |
|
|
LGTY
1859
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $107K | ﹤0.01% |
10,208
-10,961
| -52% | -$115K |
|
1860
Mirion Technologies
MIR
$5.28B
| $104K | ﹤0.01% |
12,332
-2,135
| -15% | -$18K |
|
1861
Vanda Pharmaceuticals
VNDA
$272M
| $102K | ﹤0.01% |
15,406
-2,028
| -12% | -$13.4K |
|
1862
Alector
ALEC
$305M
| $101K | ﹤0.01% |
16,869
+309
| +2% | +$1.85K |
|
|
CIM
1863
Chimera Investment
CIM
$1.2B
| $101K | ﹤0.01% |
5,843
-2,749
| -32% | -$47.5K |
|
1864
Fate Therapeutics
FATE
$116M
| $101K | ﹤0.01% |
21,303
-2,644
| -11% | -$12.5K |
|
1865
ImmunityBio
IBRX
$2.27B
| $99K | ﹤0.01% |
35,440
-1,555
| -4% | -$4.34K |
|
1866
Ramaco Resources Class A
METC
$1.86B
| $99K | ﹤0.01% |
12,091
-8,364
| -41% | -$68.5K |
|
1867
Cushman & Wakefield
CWK
$3.84B
| $98K | ﹤0.01% |
11,981
-4,341
| -27% | -$35.5K |
|
1868
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $96K | ﹤0.01% |
22,477
+3,309
| +17% | +$14.1K |
|
|
BLUE
1869
DELISTED
bluebird bio
BLUE
| $95K | ﹤0.01% |
1,442
-143
| -9% | -$9.42K |
|
1870
Summit Therapeutics
SMMT
$19.3B
| $95K | ﹤0.01% |
+37,856
| New | +$95K |
|
1871
Uranium Energy
UEC
$4.96B
| $92K | ﹤0.01% |
26,992
-13,610
| -34% | -$46.4K |
|
1872
Emergent Biosolutions
EBS
$404M
| $90K | ﹤0.01% |
12,304
-1,527
| -11% | -$11.2K |
|
1873
Aurora
AUR
$10.6B
| $85K | ﹤0.01% |
28,998
-8,062
| -22% | -$23.6K |
|
1874
Evolus
EOLS
$495M
| $83K | ﹤0.01% |
11,461
+198
| +2% | +$1.43K |
|
1875
Helix Energy Solutions
HLX
$933M
| $80K | ﹤0.01% |
10,884
-5,158
| -32% | -$37.9K |
|